Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), today announced the appointment of veteran life sciences venture capitalist and executive ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE